C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies

TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics.Continue reading

City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen

PHOENIX, NOVEMBER 7, 2023 — City of Hope®, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope. He joins City of Hope from Mayo Clinic, where he served as chair of the Division of Hematology and Medical Oncology in the Department of Internal Medicine at Mayo Clinic in Arizona and director of Mayo Clinic Comprehensive Cancer Center in Arizona. Continue reading

ASU researchers working to develop biomarkers to screen for HPV-related cancer

Oropharyngeal cancer — a type of cancer that is difficult to diagnose, treat — is on the rise
Recent studies have highlighted a concerning trend: a rise in oropharyngeal cancer — difficult to diagnose and difficult to treat — linked to the human papillomavirus (HPV). Researchers are keen to spread awareness about this connection, emphasizing the importance of HPV vaccinations for both men and women and expanded testing for those at risk.Continue reading